Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (3087)	9/15/2005 12:39:15 PM
From: tom pope	Read Replies (1) \| Respond to of 12215

How about CRIS for basal cell carcinoma (I learn about it once a year from my dermatologist :-( - 3 this year, a new personal best. GENR. I know Dew doesn't like it, but the payoff if it works and is safe would be huge.

To: scaram(o)uche who wrote (3087)	9/15/2005 12:47:35 PM
From: Galirayo	Read Replies (1) \| Respond to of 12215

Hey Rick .. ACAD looks the best to me at the moment. Of course ... you know ... I'm Chart Gazing. :) Do you like SGMO ? Regards! Ray

To: scaram(o)uche who wrote (3087)	9/15/2005 1:55:51 PM
From: tuck	Respond to of 12215

MSHL? (Adding more on the weakness today) Cheers, Tuck

To: scaram(o)uche who wrote (3087)	9/15/2005 2:07:02 PM
From: Tomato	Read Replies (1) \| Respond to of 12215

Post mortems for the ones no longer on the list, i.e. PARS, KOSN, EXEL, PTN, and RIGL?

To: scaram(o)uche who wrote (3087)	9/15/2005 2:13:45 PM
From: Extra Pale	Respond to of 12215

second gnvc, throw in long-time disappointment isis.

To: scaram(o)uche who wrote (3087)	9/15/2005 3:35:29 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 12215

Sorry if I repeat myself... Straight face: Anormed. All you got to do is wait a year. Funds start to move in in 6 months, my prediction. You'll be able to take profits before P3 results, imo. Face: Acambis. Not quite the deep value, but it actually does, and owns, stuff that can be measured in money. Take out price is 2x. Not retreating from exel, incy, rigl, crme, BTW--but they are not, as there are not, that many silly cheap BTs at the moment. (agree w/acad and arna as holds.)

To: scaram(o)uche who wrote (3087)	9/15/2005 3:37:40 PM
From: rkrw	Read Replies (1) \| Respond to of 12215

How about cytk? dvax? A 1/4 the valuation of coley and in the hot tlr space.

To: scaram(o)uche who wrote (3087)	9/15/2005 4:24:37 PM
From: DewDiligence_on_SI	Read Replies (1) \| Respond to of 12215

GTCB Please see: investorshub.com Dew

To: scaram(o)uche who wrote (3087)	9/15/2005 6:47:02 PM
From: fred hayes	Read Replies (4) \| Respond to of 12215

baggers: How about PCOP and COR? Seems like you need to be small and then get lucky. Hope these at least have a chance...

To: scaram(o)uche who wrote (3087)	9/16/2005 3:05:51 PM
From: tom pope	Read Replies (1) \| Respond to of 12215

GNVC Someone is feeding a steady stream of GNVC to the market via inet. It will be interesting to see how the stock reacts when the seller is finished.

To: scaram(o)uche who wrote (3087)	9/20/2005 10:07:15 AM
From: SnowShredder	Read Replies (1) \| Respond to of 12215

Hi Rick, Thoughts, everyone? What do you have plenty of, that you also feel BELONGS in a smallcap basket?? I like Cytori Therapeutics (CYTDF.PK)as a bagger, but you probably could of already guessed that. How much in the next year? I won't comment, but if stem cells are going to make it, I think they have as good of a shot as any. Especially since the source of the cells won't disable you, and it avoids various transplatation concerns...bwdik? Best of Luck, SS (disclaimer I got plenty and it's not very liquid)

To: scaram(o)uche who wrote (3087)	9/20/2005 11:08:44 PM
From: D.Lu	Read Replies (1) \| Respond to of 12215

Concerning the 20x strategy A year (14 months) later, and VPHM has put in 12X of that 20. So, we picked at least one good one. One good one is ALL that any smallcap bioinvestor needs. One problem is in identifying and holding the 10X or 20X. I sold out of VPHM-at a good profit- just below $5- never imagining it could rise to the high teens. In a trading environment it just seemed to make sense at the time.

To: scaram(o)uche who wrote (3087)	9/21/2005 9:12:36 AM
From: tom pope	Read Replies (2) \| Respond to of 12215

Damn GNVC 8:09AM Genvec to sell 7.25 mln shares at $2.00 to institutional investors (GNVC) 2.45 :Co announced that it has obtained commitments to purchase shares of its common stock in a registered direct offering for gross proceeds of $14.5 mln. Under the terms of the transaction, GenVec will sell 7,250,000 shares of its common stock at $2.00 per share to a group of institutional investors. The closing of the offering is expected to take place on September 26, 2005, subject to the satisfaction of customary closing conditions. A shelf registration statement relating to these securities was declared effective by the SEC on April 28, 2005.